Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire
- Yonglan Liu
- , Mingzhen Zhang
- , Hyunbum Jang
- , Ruth Nussinov*
*Corresponding author for this work
- National Institutes of Health
- Leidos Inc
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations